Tol-Tab Package insert


  • Pill
  • The intravenous formulation of TOLBUTamide was discontinued by the manufacturer on March 6
  • 2002. Diabetes mellitus type 2 Neoplasm of pancreas; Diagnosis
Back to: Full Site Navigation

FDA package inserts for Tol-Tab (Tolbutamide)

This is the FDA package insert, supplied by pharmaceutical companies

Downloading FDA Package Insert for tolbutamide tablet